share_log

康龍化成:(1) 建議採納2022年A股激勵計劃及考核管理辦法;(2) 根據特別授權建議發行及授出2022年A股激勵計劃項下的新A股;及(3) 建議授權董事會辦理2022年A股激勵計劃相關事宜

Pharmaron Beijing Co., Ltd.*: (1) PROPOSED ADOPTION OF THE 2022 A SHARE INCENTIVE SCHEME AND THE ASSESSMENT MANAGEMENT MEASURES; (2) PROPOSED ISSUE AND GRANT OF THE NEW A SHARES UNDER THE 2022 A SHARE INCENTIVE SCHEME PURSUANT TO SPECIFIC MANDATE; AND (3)

Mar 27, 2022 06:52
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more